Respiratory Motion Obtains $5,800,000 Series B Financing Round

  • Feed Type
  • Date
    2/27/2014
  • Company Name
    Respiratory Motion
  • Mailing Address
    411 Waverly Oaks Rd. Waltham, MA 02452
  • Company Description
    Respiratory Motion, Inc. (RMI) is a new generation medical device company developing and commercializing the ExSpironTM. RMI’s goal is to cost-effectively improve the standard of care in respiration monitoring. Ventilation monitoring is increasingly recommended as oxygen saturation levels inadequately predict ventilatory distress.
  • Website
    http://www.respiratorymotion.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,800,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funds raised will support sales and marketing of the Company’s innovative ExSpiron respiration monitoring system.
  • M&A Terms
  • Venture Investor
    Easton Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.